MIMEDX GROUP, INC.(MDXG)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

MIMEDX GROUP, INC. (MDXG) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MDXG at 43.9/100 on a 32-signal composite quality model, placing it at rank #1,950 of 2,962 stocks — the bottom half of the AI-ranked universe. MDXG scores in the top quartile across earnings quality (97.4). Areas of concern include profitability (28.6) and revenue scale (32.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 28.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), MIMEDX GROUP, INC. reports quarterly revenue of $64.4M, net income of $-14.8M. Top institutional holders of MDXG by reported 13-F value include Essex Woodlands Management, BlackRock, Trigran Investments, based on the most recent SEC filings. MDXG trades on the Nasdaq exchange and files with the SEC under CIK 1376339. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDXG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MIMEDX GROUP, INC. directly from SEC EDGAR.